But “treatment” does not mean helping existing sufferers. Rather, the techniques might allow a small subset of women with mitochondrial disease (in the UK, roughly 10-20 annually) to reduce the risk that their children will inherit the mutation – at the cost of setting a precedent with serious potential consequences.